Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: IAG, Dr. Martens, Ascential

(Sharecast News) - JPMorgan Cazenove placed shares of BA and Iberia owner IAG on 'positive catalyst watch' on Wednesday ahead of first-quarter results and following minor changes to estimates published yesterday.

JPM noted that Q1 is seasonally the smallest quarter in terms of EBIT contribution for the network carriers, and seasonality has shifted more towards Q2-Q3 post pandemic given the strong leisure demand and lack of full corporate recovery.

"However, in our view the Q1 results could be a catalyst to spur consensus 2024E EBIT upgrades on the stock, given a more positive pricing backdrop both for Q1 and into the summer (we currently forecast passenger unit revenue growth up slightly for 2024E)," it said.

"We would not anticipate any cost offsets (excluding any unexpected disruption), with Q1 expected to be the worst quarter for ex-fuel CASK (cost of available seat kilometre) pressure, and included within the +1-2% 2024E guidance already."

JPM is forecasting 2024E EBIT of €3.7bn - no explicit guidance was given previously at the 2023 results - which is around 8% ahead of Bloomberg median consensus.

The bank has an 'overweight' rating on the stock and a €2.50 price target.

RBC Capital Markets cut its price target on Dr Martens on Wednesday to 85p from 100p as it lowered its estimates for FY24-26 earnings per share by 7% to 10%.

The bank said Dr Martens should be able to deliver on materially lower guided and consensus expectations for FY24, due 30 May.

The bank said Spring/Summer shipment timings could be a swing factor, however it believes Q4 DTC trends will be an important data point as well as FY25.

RBC said it expects the company's FY25 guidance to strike a "cautious tone". It expects revenue guidance of 'mid-single digit' and an EBITDA guidance range of £200m to £210m, which implies mid-high single-digit growth year-on-year.

RBC rates the shares at 'sector perform'.

Analysts at Citi told clients they saw more than 20% upside in shares of Ascential, when not more.

That was true even when factoring in "conservative" valuations for the company's stake in Hudson MX and for its core Events business, they said in a research note sent to clients.

Indeed, their 225p target price together with the expected special dividend yielded a 'fair value' for the shares of 380p in "today's money".

Furthermore, a blue sky scenario in which the events business was valued at 12 times EV/EBITDA and Hudson MX sold for over £100m would result in a fair value of 450p per share.

Citi analysts said they remained buyers of the shares.

Share this article

Related Sharecast Articles

Asia report: Most markets rise as yen falls back
(Sharecast News) - Asian markets saw a mixed day of trading on Tuesday, as investors navigated between positive cues from Wall Street and cautious sentiment surrounding China's factory activity.
Europe open: Shares in cautious mood ahead of EZ data
(Sharecast News) - European markets opened lower on Tuesday ahead of eurozone data and amid another dump of corporate earnings and update news.
London open: FTSE gains as investors eye Fed meeting; HSBC rallies
(Sharecast News) - London stocks rose in early trade on Tuesday, helped along by solid performances from the likes of HSBC and Coca-Cola HBC, as investors eyed the start of the Federal Reserve's two-day policy meeting.
London pre-open: Stocks seen up as investors eye Fed
(Sharecast News) - London stocks were set to rise at the open on Tuesday following a positive US close, as investors eyed the start of the latest Federal Reserve policy meeting.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.